Target intelligence / Profile preview

Influenza A virus hemagglutinin stem region (HA stem) (HA stem)

Target
HA stem
Molecular classification
Viral surface glycoprotein, Class I fusion protein
01

Overview

The Influenza A virus hemagglutinin (HA) stem region is a highly conserved domain of the HA surface glycoprotein, primarily composed of the HA2 subunit and portions of the HA1 subunit [1]. Unlike the highly variable globular head region, the stem region remains relatively constant across different influenza strains and subtypes, making it a prime target for the development of universal influenza vaccines and broad-spectrum therapeutics [2]. Its primary biological role is to mediate the fusion of the viral envelope with the host cell's endosomal membrane during viral entry [1]. This process is triggered by the acidic environment of the endosome, which induces a massive, irreversible conformational change in the stem region, often described as a spring-loaded mechanism [3]. Therapeutic agents, such as broadly neutralizing antibodies (bnAbs) and certain small molecules, bind to this conserved pocket to stabilize the pre-fusion state and physically block the fusion machinery [4]. By inhibiting this critical step of the viral life cycle, these drugs can provide protection against a wide range of influenza A viruses, including both seasonal and pandemic-potential strains [3]. Sources: [1] PubMed: 28100931; [2] Science: 10.1126/science.aac7263; [3] Science: 10.1126/science.1208530; [4] Science: 10.1126/science.aar6221.

Other names
Hemagglutinin stalk regionHA2 subunitConserved stem domainHA stalk
02

Mechanism of action

Binding to the conserved stem region prevents the pH-triggered conformational change of the hemagglutinin protein, thereby blocking the fusion of the viral envelope with the host endosomal membrane and preventing viral genome release into the cytoplasm.

03

Biological functions

Viral entryMembrane fusionViral-host cell membrane integrationConformational rearrangement
04

Disease associations

Influenza A infectionRespiratory tract infectionPandemic influenza
05

Safety considerations

Viral resistance through mutations in the HA2 subunitPotential for antibody-dependent enhancement (ADE)Low natural immunogenicity due to immunodominance of the HA head regionSubtype-specific limitations of some stem-binding antibodies
06

Interacting drugs

CR6261

6 more in the full profile.

07

Biomarkers

HA stem-specific antibody titers (ELISA)Viral load reduction (RT-qPCR)Microneutralization assay titers

Beyond the preview

Go deeper on Influenza A virus hemagglutinin stem region (HA stem) (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin stem region (HA stem) (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call